NIH #R35CA197568
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
Active
- Amount
- $1M–$2M
- Period
- 2015-08-01 → 2028-07-31
- PIs
- 1
Awarded at DANA-FARBER CANCER INST
Matthew Meyerson
Full Professor(heuristic)
Cancer Genomics and Diagnostics · Cancer Research
Compare more Cancer Research professors.
h-index216
i10-index456
Publications1,771
Citations294,273
Grants
5 total · 1 active
NIH #P01CA154303
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
- Amount
- $1M–$2M
- Period
- 2012-05-11 → 2022-08-31
- PIs
- 1
Awarded at DANA-FARBER CANCER INST
NIH #R01CA116020
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
- Amount
- $300K–$400K
- Period
- 2006-03-24 → 2022-03-31
- PIs
- 2
Awarded at DANA-FARBER CANCER INST
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Abstract 7064: Development of a new class of KAT6A/B inhibitors with <i>in vivo</i> efficacy. (Cancer Research)2026-04-03
- New NIH award: Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery2015-08-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-28
Data may not be current
Find elsewhere
ORCID: 0000-0002-9133-8108